|
93 Companies |
|
118 Products |
|
118 Products |
|
88 Mechanisms of Action |
|
3 Trials |
|
1622 News |
|
| «12...345678910111213...3233» |
- Enrollment change, Trial withdrawal, Combination therapy: Efficacy of Combination Therapy vs Placebo for Pediatric Functional Abdominal Pain (clinicaltrials.gov) - Aug 24, 2015
P1, N=0, Withdrawn, Sponsor: Medical College of Wisconsin
N=120 --> 0 | Not yet recruiting --> Withdrawn
- Enrollment closed, Trial primary completion date: Capsule Endoscopy for Hemorrhage in the Emergency Room (clinicaltrials.gov) - Aug 20, 2015
P=N/A, N=50, Active, not recruiting, Sponsor: George Washington University
N=120 --> 0 | Not yet recruiting --> Withdrawn Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Oct 2013 --> Jun 2017
- Trial completion: Effects of Self-administered Acupressure in Psychiatric Patients With Constipation (clinicaltrials.gov) - Aug 20, 2015
P1/2, N=78, Completed, Sponsor: The Hong Kong Polytechnic University
Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Oct 2013 --> Jun 2017 Active, not recruiting --> Completed
- | metyrosine / Generic mfg., diphenhydramine / Generic mfg.
Trial suspension, Trial primary completion date: Neural Response to Catecholamine Depletion in Subjects Suffering From Bulimia Nervosa in Their Past and Healthy Controls (clinicaltrials.gov) - Aug 14, 2015
P=N/A, N=60, Suspended, Sponsor: University of Bern
Active, not recruiting --> Completed Recruiting --> Suspended | Trial primary completion date: Oct 2014 --> May 2017
- Trial completion: Effect Of Biomechanical Stimulation On Skeletal Health In Adolescent And Young Women With Anorexia Nervosa (clinicaltrials.gov) - Aug 13, 2015
P=N/A, N=51, Completed, Sponsor: Children's Hospital Boston
Recruiting --> Suspended | Trial primary completion date: Oct 2014 --> May 2017 Recruiting --> Completed
- Enrollment change, Trial withdrawal, Head-to-Head: ACROSS: Non-Inferiority Trial Comparing Eurofarma's Experimental Product Saccharomyces Boulardii Versus Floratil® in the Prevention of Antibiotic-Associated Diarrhea (clinicaltrials.gov) - Aug 12, 2015
P3, N=0, Withdrawn, Sponsor: Eurofarma Laboratorios S.A.
Recruiting --> Completed N=1053 --> 0 | Not yet recruiting --> Withdrawn
- Trial completion: CONSTIMOD: Efficacy of Sacral Nerve Modulation in Severe Refractory Constipation (clinicaltrials.gov) - Aug 12, 2015
P2, N=20, Completed, Sponsor: University Hospital, Bordeaux
N=1053 --> 0 | Not yet recruiting --> Withdrawn Active, not recruiting --> Completed
- | oxycodone/naloxone ER / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date, HEOR: Non-interventional Study Comparing Targiniq and Oxycodone/Laxatives (clinicaltrials.gov) - Aug 12, 2015
P=N/A, N=37, Completed, Sponsor: Mundipharma AB
Active, not recruiting --> Completed Recruiting --> Completed | N=200 --> 37 | Trial primary completion date: Mar 2014 --> Jun 2015
- Trial completion, Trial primary completion date: Decreasing Stress and Improving Self-control With "Stress in Control" (Sync) Training (clinicaltrials.gov) - Aug 11, 2015
P1, N=112, Completed, Sponsor: Yale University
Recruiting --> Completed | N=200 --> 37 | Trial primary completion date: Mar 2014 --> Jun 2015 Recruiting --> Completed | Trial primary completion date: Sep 2013 --> Jan 2013
- ||| RotaTeq (Live attenuated pentavalent Rotavirus oral vaccine) / Merck (MSD)
Enrollment closed, Trial primary completion date: An Alternate Dosing Schedule for Pentavalent Rotavirus Vaccine (RotaTeq) (clinicaltrials.gov) - Aug 11, 2015
P4, N=60, Active, not recruiting, Sponsor: Emmanuel Walter
Recruiting --> Completed | Trial primary completion date: Sep 2013 --> Jan 2013 Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Dec 2015
- ||||||| Sustol (granisetron ER) / Heron Therapeutics
Trial completion: A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC (clinicaltrials.gov) - Jul 21, 2015
P3, N=942, Completed, Sponsor: Heron Therapeutics
Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Dec 2015 Active, not recruiting --> Completed
- Enrollment change, Trial withdrawal: Efficacy and Safety of Polyethylene Glycol 3350 (PEG 3350) for Relief of Constipation (MK-8114-005) (clinicaltrials.gov) - Jul 16, 2015
P3, N=0, Withdrawn, Sponsor: Bayer
Active, not recruiting --> Completed N=120 --> 0 | Not yet recruiting --> Withdrawn
- topiramate / Generic mfg.
Enrollment change: Topiramate Augmentation in Bulimia Nervosa Partial Responders (clinicaltrials.gov) - Jul 15, 2015
P4, N=0, Withdrawn, Sponsor: Neuropsychiatric Research Institute, Fargo, North Dakota
N=120 --> 0 | Not yet recruiting --> Withdrawn N=10 --> 0
- | Ibodutant (MEN 15596) / Menarini
Trial completion: IRIS-3: 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) (clinicaltrials.gov) - Jul 15, 2015
P3, N=500, Completed, Sponsor: Menarini Group
N=10 --> 0 Active, not recruiting --> Completed
- Enrollment change, Trial withdrawal: Probiotic Therapy in Preventing Gastrointestinal Complications in Patients Undergoing Chemotherapy and Pelvic Radiation Therapy (clinicaltrials.gov) - Jul 13, 2015
P3, N=0, Withdrawn, Sponsor: Alliance for Clinical Trials in Oncology
Active, not recruiting --> Completed N=140 --> 0 | Not yet recruiting --> Withdrawn
- Trial primary completion date: Urinary Markers for Unilateral Kidney Obstruction (clinicaltrials.gov) - Jul 10, 2015
P=N/A, N=100, Recruiting, Sponsor: Carmel Medical Center
N=140 --> 0 | Not yet recruiting --> Withdrawn Trial primary completion date: Oct 2014 --> Nov 2015
- ||| Trial completion, Enrollment change, Trial primary completion date: Longitudinal Study of Patients With Opioid-Induced Constipation (clinicaltrials.gov) - Jul 9, 2015
P=N/A, N=520, Completed, Sponsor: AstraZeneca
Trial primary completion date: Oct 2014 --> Nov 2015 Recruiting --> Completed | N=900 --> 520 | Trial primary completion date: Apr 2014 --> Dec 2014
- | Xifaxan (rifaximin) / Alfa Wassermann, Bausch Health, Norgine, ASKA Pharma
Enrollment change: TARGET3t: Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study (clinicaltrials.gov) - Jul 9, 2015
P3, N=2583, Completed, Sponsor: Salix Pharmaceuticals
Recruiting --> Completed | N=900 --> 520 | Trial primary completion date: Apr 2014 --> Dec 2014 N=800 --> 2583
- Trial completion: Cancer Anorexia and the Central Nervous System (clinicaltrials.gov) - Jul 9, 2015
P=N/A, N=15, Completed, Sponsor: University of Roma La Sapienza
N=800 --> 2583 Recruiting --> Completed
- Trial completion, Enrollment change, Trial primary completion date: Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer (clinicaltrials.gov) - Jul 9, 2015
P2, N=7, Completed, Sponsor: Alliance for Clinical Trials in Oncology
Recruiting --> Completed Active, not recruiting --> Completed | N=75 --> 7 | Trial primary completion date: Aug 2011 --> Jan 2011
- | Trial completion: Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer (clinicaltrials.gov) - Jul 9, 2015
P3, N=129, Completed, Sponsor: Alliance for Clinical Trials in Oncology
Active, not recruiting --> Completed | N=75 --> 7 | Trial primary completion date: Aug 2011 --> Jan 2011 Active, not recruiting --> Completed
- Trial primary completion date: FAKT: Treatment of Eating Disorders by Physical Activity and Nutrition Counseling (clinicaltrials.gov) - Jun 30, 2015
P=N/A, N=150, Recruiting, Sponsor: Norwegian School of Sport Sciences
Active, not recruiting --> Completed Trial primary completion date: Jun 2015 --> Jun 2016
- Enrollment closed, Enrollment change, Trial primary completion date: Kappa Opioid Receptor Imaging in Anorexia (clinicaltrials.gov) - Jun 29, 2015
P=N/A, N=7, Active, not recruiting, Sponsor: New York University School of Medicine
Trial primary completion date: Jun 2015 --> Jun 2016 Recruiting --> Active, not recruiting | N=14 --> 7 | Trial primary completion date: Sep 2017 --> Mar 2015
- Enrollment open, Enrollment change, Trial primary completion date: Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation-induced Modulation of Hyperphagia in Prader-Willi Syndrome (clinicaltrials.gov) - Jun 29, 2015
P=N/A, N=60, Recruiting, Sponsor: Merlin G. Butler, MD, PhD
Recruiting --> Active, not recruiting | N=14 --> 7 | Trial primary completion date: Sep 2017 --> Mar 2015 Active, not recruiting --> Recruiting | N=36 --> 60 | Trial primary completion date: Apr 2014 --> Jul 2017
- Trial completion: Feasibility Study of Oral Naloxone for Treatment of Methadone-induced Constipation (clinicaltrials.gov) - Jun 24, 2015
P2, N=20, Completed, Sponsor: Centre for Addiction and Mental Health
Active, not recruiting --> Recruiting | N=36 --> 60 | Trial primary completion date: Apr 2014 --> Jul 2017 Recruiting --> Completed
- Emend intravenous (fosaprepitant) / Merck (MSD), Ono Pharma, Sancuso (granisetron) / Solasia
Trial primary completion date: Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy (clinicaltrials.gov) - Jun 24, 2015
P=N/A, N=40, Recruiting, Sponsor: University of Southern California
Recruiting --> Completed Trial primary completion date: Sep 2015 --> Sep 2016
- Trial initiation date, Trial primary completion date: Lactose-free Milk in Infants With Acute Diarrhea in a Developing Country (clinicaltrials.gov) - Jun 23, 2015
P=N/A, N=40, Not yet recruiting, Sponsor: American University of Beirut Medical Center
Trial primary completion date: Sep 2015 --> Sep 2016 Initiation date: Oct 2014 --> Jul 2015 | Trial primary completion date: Apr 2015 --> Jun 2016
- Enrollment change: The Treatment of Recurrent Abdominal Pain in Children (clinicaltrials.gov) - Jun 23, 2015
P=N/A, N=0, Withdrawn, Sponsor: Kaiser Permanente
Initiation date: Oct 2014 --> Jul 2015 | Trial primary completion date: Apr 2015 --> Jun 2016 N=50 --> 0
- Enrollment change, Trial termination, Trial primary completion date: Does Thiamine Help Vomiting and Nausea in Pregnancy? (clinicaltrials.gov) - Jun 23, 2015
P3, N=50, Terminated, Sponsor: HaEmek Medical Center, Israel
N=50 --> 0 N=280 --> 50 | Recruiting --> Terminated | Trial primary completion date: Apr 2011 --> Jan 2012; Difficulties in recruiting patients
- ||||||| Trial completion, Enrollment change, Trial primary completion date: Lactobacillus Reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children (clinicaltrials.gov) - Jun 18, 2015
P3, N=184, Completed, Sponsor: Medical University of Warsaw
N=280 --> 50 | Recruiting --> Terminated | Trial primary completion date: Apr 2011 --> Jan 2012; Difficulties in recruiting patients Recruiting --> Completed | N=106 --> 184 | Trial primary completion date: Aug 2014 --> Feb 2015
- ||||| Movantik (naloxegol) / AstraZeneca, RedHill, Kyowa Kirin
Enrollment change: A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation (clinicaltrials.gov) - Jun 17, 2015
P3, N=302, Completed, Sponsor: AstraZeneca
Recruiting --> Completed | N=106 --> 184 | Trial primary completion date: Aug 2014 --> Feb 2015 N=633 --> 302
- || Trial primary completion date: Bihar Evaluation of Social Franchising and Telemedicine (clinicaltrials.gov) - Jun 16, 2015
P=N/A, N=106380, Active, not recruiting, Sponsor: Duke University
N=633 --> 302 Trial primary completion date: Apr 2015 --> Dec 2014
- Trial primary completion date: Engaging Latino Families in Eating Disorders Treatment (clinicaltrials.gov) - Jun 12, 2015
P=N/A, N=40, Active, not recruiting, Sponsor: Mae Lynn Reyes-Rodriguez, PhD
Trial primary completion date: Apr 2015 --> Dec 2014 Trial primary completion date: Apr 2015 --> Apr 2016
- |||| relenopride (YKP-GI) / SK Bio
Trial completion: Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation (clinicaltrials.gov) - Jun 12, 2015
P2, N=273, Completed, Sponsor: SK Chemicals Co.,Ltd.
Trial primary completion date: Apr 2015 --> Apr 2016 Recruiting --> Completed
- Trial primary completion date: Efficacy of Metronidazole Prophylaxis Against Clostridium Difficile-Associated Diarrhea in High Risk Adult Patients (clinicaltrials.gov) - Jun 11, 2015
P4, N=600, Recruiting, Sponsor: Alison Schneider
Recruiting --> Completed Trial primary completion date: Jul 2015 --> Dec 2015
- Cesamet (nabilone) / Bausch Health, Viatris
Trial primary completion date, Surgery: Study of Prevention of Postoperative Nausea and Vomiting Using Cesamet (clinicaltrials.gov) - Jun 11, 2015
P2, N=330, Recruiting, Sponsor: St. Michael's Hospital, Toronto
Trial primary completion date: Jul 2015 --> Dec 2015 Trial primary completion date: Apr 2015 --> Apr 2016
- Trial primary completion date: Neural Links Between OCD and Anorexia (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=45, Recruiting, Sponsor: Stanford University
Trial primary completion date: Apr 2015 --> Apr 2016 Trial primary completion date: Jan 2015 --> Jan 2016
- Acetavance (acetaminophen) / Mallinckrodt
Trial primary completion date: IV Acetaminophen for Postoperative Analgesia (clinicaltrials.gov) - Jun 11, 2015
P4, N=224, Recruiting, Sponsor: North Shore Long Island Jewish Health System
Trial primary completion date: Jan 2015 --> Jan 2016 Trial primary completion date: Mar 2015 --> Jul 2015
- Trial primary completion date: Internet Intervention for Adolescents With Chronic Pain (clinicaltrials.gov) - Jun 11, 2015
P2, N=600, Active, not recruiting, Sponsor: Seattle Children's Hospital
Trial primary completion date: Mar 2015 --> Jul 2015 Trial primary completion date: Mar 2015 --> Aug 2015
- || Trial primary completion date: CBT4BN: Online Cognitive Behavioral Therapy for Bulimia Nervosa (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=180, Active, not recruiting, Sponsor: University of North Carolina, Chapel Hill
Trial primary completion date: Mar 2015 --> Aug 2015 Trial primary completion date: Sep 2014 --> Jan 2016
- Enrollment change, Trial withdrawal: Identifiable Factors That May Lead to Postoperative Nausea and Vomiting After Simple Laparoscopic Appendectomy (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=0, Withdrawn, Sponsor: Brian Kenney
Trial primary completion date: Sep 2014 --> Jan 2016 N=200 --> 0 | Recruiting --> Withdrawn
- Enrollment open, Trial primary completion date: Internet-delivered CBT for Functional Abdominal Pain in Adolescents - a Pilot (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=40, Recruiting, Sponsor: Karolinska Institutet
N=200 --> 0 | Recruiting --> Withdrawn Not yet recruiting --> Recruiting | Trial primary completion date: Feb 2016 --> Nov 2016
- ||| relamorelin (RM-131) / AbbVie
Enrollment closed, P2 data: MOVE-PD: A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation (clinicaltrials.gov) - Jun 11, 2015
P2, N=56, Active, not recruiting, Sponsor: Rhythm Pharmaceuticals, Inc.
Not yet recruiting --> Recruiting | Trial primary completion date: Feb 2016 --> Nov 2016 Recruiting --> Active, not recruiting
- |||| ranolazine ER / Generic mfg.
Trial primary completion date: Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D (clinicaltrials.gov) - Jun 11, 2015
P2/3, N=60, Recruiting, Sponsor: Mayo Clinic
Recruiting --> Active, not recruiting Trial primary completion date: Sep 2015 --> Dec 2015
- Emend intravenous (fosaprepitant) / Merck (MSD), Ono Pharma
Trial primary completion date: Fosaprepitant in Patients Receiving Ifosfamide-based Regimen (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=47, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Sep 2015 --> Dec 2015 Trial primary completion date: May 2016 --> Mar 2015
- Phase classification: PK Study of iOWH032 in Adult Male/Female Healthy Volunteers & Adult Males With Cholera (clinicaltrials.gov) - Jun 11, 2015
P1, N=26, Completed, Sponsor: PATH
Trial primary completion date: May 2016 --> Mar 2015 Phase classification: P1/2 --> P1
- Xifaxan (rifaximin) / Alfa Wassermann, Bausch Health, Norgine, ASKA Pharma
Enrollment change: Single Daily Dose Rifaximin for the Treatment of Travelers' Diarrhea (clinicaltrials.gov) - Jun 10, 2015
P4, N=0, Withdrawn, Sponsor: The University of Texas Health Science Center, Houston
Phase classification: P1/2 --> P1 N=300 --> 0
- | Enrollment closed, Trial primary completion date: Hormonal Therapy for Teens With Anorexia Nervosa (clinicaltrials.gov) - Jun 6, 2015
P3, N=70, Active, not recruiting, Sponsor: Children's Hospital Boston
N=300 --> 0 Recruiting --> Active, not recruiting | Trial primary completion date: May 2015 --> Jan 2015
- ||| Linzess (linaclotide) / Astellas, Ironwood Pharma, AbbVie
Enrollment closed: Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain (clinicaltrials.gov) - Jun 4, 2015
P2, N=240, Active, not recruiting, Sponsor: Forest Laboratories
Recruiting --> Active, not recruiting | Trial primary completion date: May 2015 --> Jan 2015 Recruiting --> Active, not recruiting
- Movantik (naloxegol) / AstraZeneca, RedHill, Kyowa Kirin
Enrollment change, Trial termination: Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain (clinicaltrials.gov) - Jun 1, 2015
P3, N=14, Terminated, Sponsor: AstraZeneca
Recruiting --> Active, not recruiting N=336 --> 14 | Completed --> Terminated; The study was stopped early due to recruitment challenges